Novel brain mapping approach finds targets for future clinical trials in depression and Parkinson’s disease
Researchers have made significant advancements in correlating aberrations in specific brain circuits with neuropsychiatric conditions like depression. However, it remains difficult to prove that damage to these circuits causes the symptoms themselves and that targeting them with therapeutics could help patients. By integrating brain lesion datasets with data on how two treatments — deep brain […]
Review the Stanford Accelerated Intelligent Neuromodulation Therapy for Treatment
Learn about the 5 day SAINT protocol for Treatment Resistant Depression here: https://psychiatryonline.org/doi/10.1176/appi.pn.2022.10.10.40
